HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Summaries for patients. Adding infliximab to the treatment regimen for polymyalgia rheumatica.

Authors
JournalAnnals of internal medicine (Ann Intern Med) Vol. 146 Issue 9 Pg. I20 (May 01 2007) ISSN: 1539-3704 [Electronic] United States
PMID17470827 (Publication Type: Patient Education Handout)
Chemical References
  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Glucocorticoids
  • Placebos
  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Prednisone
Topics
  • Aged
  • Antibodies, Monoclonal (adverse effects, therapeutic use)
  • Antirheumatic Agents (adverse effects, therapeutic use)
  • Double-Blind Method
  • Drug Therapy, Combination
  • Female
  • Glucocorticoids (adverse effects, therapeutic use)
  • Humans
  • Infliximab
  • Male
  • Middle Aged
  • Placebos
  • Polymyalgia Rheumatica (drug therapy)
  • Prednisone (adverse effects, therapeutic use)
  • Recurrence
  • Remission Induction
  • Tumor Necrosis Factor-alpha (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: